No Data
No Data
Jefferies Downgrades ALX Oncology(ALXO.US) to Hold Rating, Cuts Target Price to $2
Sector Update: Health Care Stocks Decline Late Afternoon
Sector Update: Health Care
ALX Oncology Shares Are Trading Lower After Jefferies Downgraded the Stock From Buy to Hold and Cut Its Price Target From $12 to $2.
Top Midday Decliners
Jefferies Downgrades ALX Oncology Holdings to Hold, Lowers Price Target to $2
No Data